Clinical Trial: Study With Immunotherapy Combinations in Participants With Metastatic Non-Small Cell Lung Cancer
Study Status: Completed
Recruit Status: RECRUITING
Condition: Advanced Non-Small Cell Lung Cancer
Study Type: INTERVENTIONAL
Official Title: A Phase II, Open-label, Platform Study, to Evaluate Immunotherapy-based Combinations in Participants With Advanced Non-Small Cell Lung Cancer
Brief Summary:
The purpose of this study is to assess the objective response rate (ORR) of immunotherapy-based combination therapy and to assess the safety and tolerability of immunotherapy-based combination therapy.
Read more